Table of Contents

Message from the President Joshua Dalton

Message from the Editor

Upcoming Event - Intellectual Property in the Age of AI: What Do You Own and How Do You Balance Risks

BIPLA Annual Writing Competition

BIPLA Pro Bono Award

BIPLA Annual Celebration of the Judiciary

BIPLA Patent Office Practice Committee Prepares Comments Regarding the USPTO Notice of Proposed Rulemaking on Terminal Disclaimers and Double Patenting

Review of Recent Antibody Case Law at the European Patent Office

Updated Guidelines for AI Inventions

New Test for Obviousness of Design Patents Presents Uncertainties and Opportunities

Review of Recent SPC Case Law in the UK – Little Appetite for Divergence From the EU

Noncompete Ban Turns Patents, Copyrights Into Corporate Shields

Brazil's Accession to the Hague System: Milestones, Impact, and Future Prospects

Update from the USPTO Patent Pro Bono Team

Celebrating 100 Years of BIPLA - Share Your Memories

Harbor IP

List of Officers and Board of Governors

Job Listings

< Back

< Previous Article

Table of Contents

Next Article >

NEWSLETTER ARCHIVE

Volume 55, Issue 2

Upcoming Event -Intellectual Property in the Age of AI: What Do You Own and How Do You Balance Risks

Dive into the digital deep end as we discuss how artificial intelligence is rewriting the rulebook on intellectual property.

Co-sponsored by the Association of Corporate Counsel, Northeast (ACC-NE) and BIPLA In-House Committee, this program will unpack how AI shakes up everything from trade secrets to copyright, and from IP ownership to privilege. The panel share strategies for shepherding your company’s IP rights while balancing the efficiency of technology with the need for appropriate controls.

Whether you spend time in the boardroom, at the negotiation table, or in a courtroom, you will gain crucial insights to stay a step ahead in the age of AI.

Moderator: Danielle Lemack; Assistant General Counsel & Vice President HP Hood, LLC   Panel includes: Deepika Bhayana; Senior Managing Legal Director - DELL Nick Boivin; Life Sciences Industry Patent Attorney & Consultant Charles T. Collins-Chase; Partner - Finnegan Henderson Vivek Rao; Partner - Pierce Atwood   In-House Committee Chairpersons: Lydia Olson; Canon USA Inc. Doyon Won; Voyager Therapeutics